Atlas Trials

Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma

Clinical trial NCT07600151 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07600151
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myeloma MultipleMyeloma
Start date
2026-12-01
Primary completion
2036-09-30
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.